UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

The Lancet (British edition), 2009-05, Vol.373 (9677), p.1780-1788

2009

Link zum Volltext

Verfügbarkeit prüfen

Association of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long-Term Coronary Events Following Myocardial Infarction or Unstable Angina: Results From the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease)

Journal of the American College of Cardiology, 2014-02, Vol.63 (4), p.345-354

2014

Link zum Volltext

Verfügbarkeit prüfen

HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes

Diabetes care, 2014-08, Vol.37 (8), p.2351-2358

2014

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes

The journal of clinical endocrinology and metabolism, 2012-12, Vol.97 (12), p.4701-4708

2012

Link zum Volltext

Verfügbarkeit prüfen

Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes: Real-world diabetes therapy in a clinical trial cohort

Diabetes care, 2012-05, Vol.35 (5), p.1165-1170

2012

Link zum Volltext

Verfügbarkeit prüfen

The Index of Microcirculatory Resistance Predicts Myocardial Infarction Related to Percutaneous Coronary Intervention

Circulation. Cardiovascular interventions, 2012-08, Vol.5 (4), p.515-522

2012

Link zum Volltext

Verfügbarkeit prüfen

Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial

International journal of cardiology, 2013-10, Vol.168 (6), p.5378-5384

2013

Link zum Volltext

Verfügbarkeit prüfen

Subgroup analysis: application to individual patient decisions

Medical journal of Australia, 2004-05, Vol.180 (9), p.467-469

2004

Link zum Volltext

Verfügbarkeit prüfen

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: Results from the LIPID trial

Diabetes care, 2003-10, Vol.26 (10), p.2713-2721

2003

Link zum Volltext

Verfügbarkeit prüfen

Effect of pravastatin in people with diabetes and chronic kidney disease

Journal of the American Society of Nephrology, 2005-12, Vol.16 (12), p.3748-3754

2005

Link zum Volltext

Verfügbarkeit prüfen

Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors : The prospective pravastatin pooling project

Circulation (New York, N.Y.), 2000-10, Vol.102 (16), p.1893-1900

2000

Link zum Volltext

Verfügbarkeit prüfen

Safety and tolerability of Pravastatin in long-term clinical trials: Prospective Pravastatin Pooling (PPP) project

Circulation (New York, N.Y.), 2002-05, Vol.105 (20), p.2341-2346

2002

Link zum Volltext

Verfügbarkeit prüfen

Relationship between lipid levels and clinical outcomes in the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID): Trial to what extent is the reduction in coronary events with Pravastatin explained by on-study lipid levels?

Circulation (New York, N.Y.), 2002-03, Vol.105 (10), p.1162-1169

2002

Link zum Volltext

Verfügbarkeit prüfen

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

The Lancet (British edition), 2000-04, Vol.355 (9212), p.1295-1302

2000

Link zum Volltext

Verfügbarkeit prüfen

Coronary heart disease in patients with low LDL-cholesterol: Benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors

Circulation (New York, N.Y.), 2002-03, Vol.105 (12), p.1424-1428

2002

Link zum Volltext

Verfügbarkeit prüfen

Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study

European heart journal, 2004-05, Vol.25 (9), p.771-777

2004

Link zum Volltext

Verfügbarkeit prüfen

Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women

Clinical endocrinology (Oxford), 1996-10, Vol.45 (4), p.435-441

1996

Link zum Volltext

Verfügbarkeit prüfen

Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study

The Lancet (British edition), 2000-12, Vol.356 (9245), p.1871-1875

2000

Link zum Volltext

Verfügbarkeit prüfen

Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease

European heart journal, 2002-10, Vol.23 (19), p.1509-1515

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 19 von 19

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe New England Journal Of Medicine

ThemaCardiovascular Disease

ThemaAged

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)
Japanisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

Association of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long-Term Coronary Events Following Myocardial Infarction or Unstable Angina: Results From the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease)

HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes

Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes

Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes: Real-world diabetes therapy in a clinical trial cohort

The Index of Microcirculatory Resistance Predicts Myocardial Infarction Related to Percutaneous Coronary Intervention

Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial

Subgroup analysis: application to individual patient decisions

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: Results from the LIPID trial

Effect of pravastatin in people with diabetes and chronic kidney disease

Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors : The prospective pravastatin pooling project

Safety and tolerability of Pravastatin in long-term clinical trials: Prospective Pravastatin Pooling (PPP) project

Relationship between lipid levels and clinical outcomes in the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID): Trial to what extent is the reduction in coronary events with Pravastatin explained by on-study lipid levels?

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

Coronary heart disease in patients with low LDL-cholesterol: Benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors

Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study

Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women

Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study

Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease

Aktive Filter

Suchergebnisse filtern